U.S. markets open in 2 hours 14 minutes
  • S&P Futures

    4,684.75
    -14.25 (-0.30%)
     
  • Dow Futures

    35,649.00
    -97.00 (-0.27%)
     
  • Nasdaq Futures

    16,328.00
    -64.25 (-0.39%)
     
  • Russell 2000 Futures

    2,257.10
    -12.70 (-0.56%)
     
  • Crude Oil

    71.86
    -0.50 (-0.69%)
     
  • Gold

    1,779.20
    -6.30 (-0.35%)
     
  • Silver

    22.22
    -0.21 (-0.95%)
     
  • EUR/USD

    1.1315
    -0.0030 (-0.26%)
     
  • 10-Yr Bond

    1.5090
    0.0000 (0.00%)
     
  • Vix

    20.59
    -1.30 (-5.94%)
     
  • GBP/USD

    1.3179
    -0.0027 (-0.21%)
     
  • USD/JPY

    113.5320
    -0.2050 (-0.18%)
     
  • BTC-USD

    49,283.72
    +314.86 (+0.64%)
     
  • CMC Crypto 200

    1,286.36
    -18.76 (-1.44%)
     
  • FTSE 100

    7,326.55
    -10.50 (-0.14%)
     
  • Nikkei 225

    28,725.47
    -135.15 (-0.47%)
     

Why Alnylam Pharmaceuticals Is Crashing Today

·2 min read
Why Alnylam Pharmaceuticals Is Crashing Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) were tanking on Thursday after the company reported its earnings results for the third quarter. The biopharmaceutical company's stock is down 14.1% as of 1:34 p.m. EDT, likely due to the company missing revenue estimates for the quarter. The company also announced its CEO, John Maraganore, will be retiring at the end of 2021.